Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-17

Clinical Trial Update: Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares donor stem cell transplantation with versus without chemotherapy in children with primary myelodysplastic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: European Working Group of MDS in Childhood | Conditions: Leukemia, Myelodysplastic/Myeloproliferative Neoplasms | Phase 3 | Status: UNKNOWN